Literature DB >> 17361232

Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.

R King1, K-P Juenemann, I P Levinson, V J Stecher, D L Creanga.   

Abstract

To explore relationships between erection hardness and other outcomes in men with erectile dysfunction (ED). Pooled analyses were conducted on 27 randomized, double-blind, placebo-controlled trials and six open-label trials from the worldwide sildenafil database. Outcomes included erection hardness graded subjectively, hardness and sexual satisfaction questions from the International Index of Erectile Function, general and sexually-specific emotional well-being from the self-esteem and relationship questionnaire, and the erectile dysfunction inventory of treatment satisfaction. Hardness outcomes improved (with a possible dose-response relationship for the achievement of fully hard and rigid erections) and correlated positively with the other outcomes. Sildenafil 100 mg produced optimal erection hardness (fully hard and rigid erections) in a substantial proportion of men with ED. Because optimal erection hardness correlated positively with some emotional well-being and satisfaction outcomes, sildenafil 100 mg may be the most appropriate dosage for treatment of ED for most men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361232     DOI: 10.1038/sj.ijir.3901549

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  6 in total

Review 1.  Eroticization as a factor influencing erectile dysfunction treatment effectiveness.

Authors:  K C Kukula; R A Jackowich; R J Wassersug
Journal:  Int J Impot Res       Date:  2013-07-04       Impact factor: 2.896

2.  Relationship between the two surgical access of aortoiliac occlusive disease and recovery of ED.

Authors:  L Verim; Y Kalko
Journal:  Int J Impot Res       Date:  2014-08-07       Impact factor: 2.896

3.  Risk factors for emotional and relationship problems in Peyronie's disease.

Authors:  James F Smith; Thomas J Walsh; Simon L Conti; Paul Turek; Tom Lue
Journal:  J Sex Med       Date:  2008-07-14       Impact factor: 3.802

4.  Hardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100-mg fixed-dose or flexible-dose sildenafil citrate.

Authors:  P Ströberg; J C Kaminetsky; N C Park; E R Goldfischer; D L Creanga; V J Stecher
Journal:  Int J Impot Res       Date:  2010-07-01       Impact factor: 2.896

5.  A web-based survey of erection hardness score and its relationship to aging, sexual behavior, confidence, and risk factors in Japan.

Authors:  Masaki Kimura; Satoru Shimura; Toshihiro Tai; Hideyuki Kobayashi; Shiro Baba; Munehide Kano; Koichi Nagao
Journal:  Sex Med       Date:  2013-12       Impact factor: 2.491

Review 6.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.